ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,513.27
0.08%
US Tech 100
19,518.00
0.20%
Dow Jones
39,328.34
-0.01%
Brent Oil
86.64
0.23%
Bitcoin
60,328.33
-2.74%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
Unknown symbol
Date:
Sort by:
DateTimeSourceHeadlineSymbolCompany
07/03/20241:30AMGlobeNewswire Inc.PRESS RELEASE: NACON LAUNCHES RIGHTS ISSUE WITH PRE-EMPTIVE RIGHTSLSE:0A9NNacon Sas
07/03/20241:30AMGlobeNewswire Inc.BGHL (GBP): NAV(s)EU:BGHSBoussard and Gavaudan Holding
07/03/20241:30AMGlobeNewswire Inc.Sampo plc’s share buybacks 2 July 2024
07/03/20241:30AMGlobeNewswire Inc.PRESS RELEASE: NACON LAUNCHES RIGHTS ISSUE WITH PRE-EMPTIVE RIGHTSEU:NACONNacon SA
07/03/20241:30AMGlobeNewswire Inc.BGHL (EUR): NAV(s)EU:BGHLBoussard And Gavaudan Holding Limited
07/03/20241:30AMGlobeNewswire Inc.COMMUNIQUE DE PRESSE: NACON LANCE UNE AUGMENTATION DE CAPITAL AVEC MAINTIEN DU DROIT PRÉFÉRENTIEL DE SOUSCRIPTIONTG:4AWNacon SA
07/03/20241:28AMPR Newswire (US)VidAU: Leading the Future of AI Video Creation with New Investment
07/03/20241:18AMAlliance NewsAlliance NewsTOP NEWS: Japan's service sector dips after 21 months of expansion
07/03/20241:15AMAlliance NewsAlliance NewsTOP NEWS: China's service sector grows by less than expected
07/03/20241:15AMBusiness WireEurofins Refutes Baseless Allegations and Misleading Information Spread by Muddy WatersNYSE:ERFEnerplus Corporation
07/03/20241:06AMAlliance NewsAlliance NewsAnglo American's Australian coal mine battles three-day blazeLSE:AALAnglo American Plc
07/03/20241:06AMAlliance NewsAlliance NewsAnglo American's Australian coal mine battles three-day blazeLSE:AALAnglo American Plc
07/03/20241:04AMBusiness WireREPAY Announces Pricing of Convertible Notes OfferingNASDAQ:RPAYRepay Holdings Corporation
07/03/20241:00AMBusiness WireCTP N.V. notice of H1-2024 results
07/03/20241:00AMBusiness Wireシカモア・ツリー・キャピタル・パートナーズ「Best US Boutique CLO Manager Award」を受賞
07/03/20241:00AMGlobeNewswire Inc.Start of Day Message
07/03/20241:00AMBusiness WireElliptic Labs Signs Expansion Contract with Commercial Segment of PC Customer
07/03/20241:00AMBusiness WireBenevolentAI: Leadership Team Change
07/03/20241:00AMGlobeNewswire Inc.Press Release: Dupixent approved in the EU as the first-ever targeted therapy for patients with COPDBIT:SANFSanofi
07/03/20241:00AMGlobeNewswire Inc.Dupixent® (dupilumab) Approved in the European Union as the First-ever Targeted Therapy for Patients with COPDNASDAQ:REGNRegeneron Pharmaceuticals Inc
07/03/20241:00AMGlobeNewswire Inc.Communiqué de presse : Dupixent devient le tout premier médicament ciblé pour le traitement de la BPCO approuvé dans l’Union européenneTG:SNWSanofi
07/03/20241:00AMGlobeNewswire Inc.Press Release: Dupixent approved in the EU as the first-ever targeted therapy for patients with COPDBIT:1SANSanofi
07/03/20241:00AMGlobeNewswire Inc.Communiqué de presse : Dupixent devient le tout premier médicament ciblé pour le traitement de la BPCO approuvé dans l’Union européenneEU:SANSanofi
07/03/20241:00AMGlobeNewswire Inc.Press Release: Dupixent approved in the EU as the first-ever targeted therapy for patients with COPDEU:SANSanofi
07/03/20241:00AMGlobeNewswire Inc.Communiqué de presse : Dupixent devient le tout premier médicament ciblé pour le traitement de la BPCO approuvé dans l’Union européenneBIT:SANFSanofi
07/03/20241:00AMGlobeNewswire Inc.Communiqué de presse : Dupixent devient le tout premier médicament ciblé pour le traitement de la BPCO approuvé dans l’Union européenneBIT:1SANSanofi
07/03/20241:00AMGlobeNewswire Inc.Press Release: Dupixent approved in the EU as the first-ever targeted therapy for patients with COPDEU:SANSanofi
07/03/20241:00AMGlobeNewswire Inc.Press Release: Dupixent approved in the EU as the first-ever targeted therapy for patients with COPDTG:SNWSanofi
07/03/20241:00AMPR Newswire (US)iTRAK 5750 Intelligent Track System from Rockwell Automation Enables Faster, More Flexible Motion Across Heavier PayloadsNYSE:ROKRockwell Automation Inc
07/03/202412:28AMAlliance NewsAlliance NewsGLOBAL BRIEFING: Europe called up as Powell revives rate cut hopes

Your Recent History

NASDAQ
TSLA
Tesla
USOTC
NNAX
New Momentum (PK)
USOTC
AABB
Asia Broadband (PK)
USOTC
AXXA
Exxe (PK)
USOTC
HMBL
HUMBL (PK)
USOTC
ELTP
Elite Pharmaceuticals (QB)
USOTC
RNVA
Rennova Health (PK)
USOTC
RSPI
RespireRx Pharmaceuticals (PK)
USOTC
TSOI
Therapeutic Solutions (PK)
USOTC
GGSM
Gold and GemStone Mining (PK)
USOTC
CATV
4Cable TV (PK)
USOTC
WDLF
Decentral Life (PK)
USOTC
TGLO
TheGlobe com (PK)
USOTC
BIEL
Bioelectronics (PK)
USOTC
DBMM
Digital Brand Media and ... (PK)
USOTC
VPLM
Voip Pal Com (QB)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved